We use cookies to give you the best possible experience. If you continue, we’ll assume you are happy to receive the cookies we place. Privacy and cookies information.
Myeloma
The Royal Marsden offers a range of myeloma treatment and care services for patients at its hospitals in Chelsea, London, and Sutton, Surrey.
Myeloma services at The Royal Marsden
- Diagnosis, tests and investigations: primary assessment and diagnosis in partnership with other hospitals
- Cancer genetics
- Chemotherapy
- Radiotherapy
- Stem cell transplant, total body irradiation
- Critical care
- Rehabilitation, including a pre-transplant programme
- Palliative and supportive care
Services are provided through a specialised inpatient unit for the delivery of more intensive chemotherapy and a newly refurbished outpatient area
Primary assessment and diagnosis
- Full blood count
- Biochemistry
- Immunoglobulins testing
- Paraprotein testing
- Serum free light chain measurement
- Bone marrow estimation
- Skeletal surveys
- MRI
- PET CT
- Bone marrow genetics
- FISH (fluorescence in situ hybridisation)
- Cytogenetics
- Novel prognostic markers
Treatment
- Stem cell transplants (autologous and allogeneic donor transplants)
- Chemotherapy using drugs such as Thalidomide, Velcade and Revlimid
- Intensive strategies for aggressive disease
- Access to novel drugs and clinical trials
Patient care and support
- Clinical nurse specialist in myeloma
- Specialist transplant nurses
- Pain control
- Orthopaedic and renal links